Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Non Operating Income of -$20.1 million for Q1 2026, down 87.92% year-over-year from -$166.7 million in Q1 2025, and down 31.62% quarter-over-quarter from -$15.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 87.92% year-over-year to -$20.1 million; the TTM figure through Mar 2026 stood at -$59.2 million (down 25.89% YoY), while the FY2025 annual figure was -$49.8 million, down 11.78% from the prior year.
- Non Operating Income for Q1 2026 stood at -$20.1 million, down from -$15.3 million in the prior quarter.
- The five-year high for Non Operating Income was $13.6 million in Q2 2023, with the low at -$20.1 million in Q1 2026.
- The 5-year median for Non Operating Income is -$8.7 million (2023), against an average of -$9.3 million.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 249.13% in 2023, then tumbled 160.13% in 2024.
- Ascend Wellness Holdings' Non Operating Income stood at -$8.5 million in 2022, then grew by 6.63% to -$7.9 million in 2023, then plunged by 52.53% to -$12.1 million in 2024, then fell by 26.4% to -$15.3 million in 2025, then tumbled by 31.62% to -$20.1 million in 2026.
- Business Quant data shows AAWH's Non Operating Income at -$20.1 million in Q1 2026, -$15.3 million in Q4 2025, and -$12.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ascend Wellness Holdings | 98.46 Mn | 31.46 Mn | 45.49 Mn | -20.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.81 Mn |
| Mar 31, 2026 | -20.13 Mn |
| Dec 31, 2025 | -15.30 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Jun 30, 2025 | -11.57 Mn |
| Mar 31, 2025 | -10.71 Mn |
| Dec 31, 2024 | -12.10 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -8.16 Mn |
| Mar 31, 2024 | -8.23 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -8.06 Mn |
| Jun 30, 2023 | 13.56 Mn |
| Mar 31, 2023 | -8.71 Mn |
| Dec 31, 2022 | -8.50 Mn |
| Sep 30, 2022 | -8.16 Mn |
| Jun 30, 2022 | -9.10 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Sep 30, 2021 | -12.33 Mn |